octamethyl pyrophosphoramide has been researched along with Myasthenia Gravis in 7 studies
*Myasthenia Gravis: A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. [MeSH]
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 7 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
MILLER, DH; WILLIAMS, JP; WILSON, CW | 1 |
FUTCH, ED; GREGORY, L; STONE, CT | 1 |
RICHTER, RB; RIDER, JA; SCHULMAN, S | 1 |
RICHTER, RB; RIDER, A; SCHULMAN, S | 1 |
KAPLAN, LI; OSSERMAN, KE | 1 |
DUBOIS, KP; MOELLER, HC; RICHTER, RB; RIDER, JA; SCHULMAN, S | 1 |
DUBOIS, KP; MOELLER, HC; RICHTER, R; RIDER, JA; SCHULMAN, S | 1 |
7 other study(ies) available for octamethyl pyrophosphoramide and Myasthenia Gravis
Article | Year |
---|---|
The hazard of cholinergic crisis during treatment of myasthenia gravis with octamethyl pyrophosphoramide.
Topics: Atropine; Cholinergic Agents; Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds | 1952 |
Octamethyl pyrophosphoramide in the therapy of myasthenia gravis.
Topics: Diphosphates; Myasthenia Gravis; Organophosphorus Compounds | 1952 |
Octamethyl pyrophosphoramide in treatment of myasthenia gravis: further observations.
Topics: Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds | 1953 |
Use of octamethyl pyrophosphoramide in the treatment of myasthenia gravis; further observations.
Topics: Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds | 1953 |
Studies in myasthenia gravis: present status of therapy with octamethyl pyrophosphoramide (OMPA).
Topics: Diphosphates; Humans; Myasthenia Gravis; Organophosphorus Compounds | 1954 |
Treatment of myasthenia gravis with octamethyl pyrophosphoramide; preliminary report.
Topics: Diphosphates; Myasthenia Gravis; Organophosphorus Compounds | 1951 |
Treatment of myasthenia gravis with octamethyl pyrophosphoramide (peptox III): a preliminary report.
Topics: Humans; Myasthenia Gravis; Organophosphorus Compounds | 1951 |